{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:37:20Z","timestamp":1781307440720,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,8,20]],"date-time":"2011-08-20T00:00:00Z","timestamp":1313798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00774-011-0299-z","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T07:42:26Z","timestamp":1313739746000},"page":"171-182","source":"Crossref","is-referenced-by-count":64,"title":["An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence"],"prefix":"10.1007","volume":"30","author":[{"given":"Nick","family":"Malden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,20]]},"reference":[{"key":"299_CR1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"299_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"299_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1834-7819.2005.tb00384.x","volume":"50","author":"A Cheng","year":"2005","unstructured":"Cheng A, Mavrokokki A, Carter G, Stein B, Fazzalari NL, Wilson DF, Goss AN (2005) The dental implications of bisphosphonates and bone disease. Aus Dent J 50:S4\u2013S13","journal-title":"Aus Dent J"},{"key":"299_CR4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"299_CR5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.14219\/jada.archive.2008.0110","volume":"139","author":"BJ Edwards","year":"2008","unstructured":"Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA, American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139:1674\u20131677","journal-title":"J Am Dent Assoc"},{"key":"299_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bdj.2007.636","volume":"203","author":"NJ Malden","year":"2007","unstructured":"Malden NJ, Pai AY (2007) Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 203:93\u201397","journal-title":"Br Dent J"},{"key":"299_CR7","doi-asserted-by":"crossref","unstructured":"Jackson I, Malden N (2007) Lingual mucosal ulceration with mandibular sequestration. Dent Update 34:573\u2013574, 576\u2013577","DOI":"10.12968\/denu.2007.34.9.573"},{"key":"299_CR8","doi-asserted-by":"crossref","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","DOI":"10.1359\/jbmr.0707onj"},{"key":"299_CR9","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B; Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 update. J Oral Maxillofac Surg 67:2\u201312","DOI":"10.1016\/j.joms.2009.01.009"},{"key":"299_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bjoms.2009.07.020","volume":"47","author":"SN Rogers","year":"2009","unstructured":"Rogers SN, Hung J, Barber AJ, Lowe D (2009) A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws. Br J Oral Maxillofac Surg 47:598\u2013601","journal-title":"Br J Oral Maxillofac Surg"},{"key":"299_CR11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","volume":"137","author":"American Dental Association Council on Scientific Affairs","year":"2006","unstructured":"American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137:1144\u20131150","journal-title":"J Am Dent Assoc"},{"key":"299_CR12","unstructured":"Statement by Merck & Co., Inc (2010) regarding Fosamax (alendronate sodium) and rare cases of osteonecrosis of the jaw. Product News. Available from: http:\/\/www.merck.com\/newsroom\/press_releases\/product\/fosamax_statement.html (Accessed March 24)"},{"key":"299_CR13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","volume":"29","author":"M Pazianas","year":"2007","unstructured":"Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P (2007) A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 29:1548\u20131558","journal-title":"Clin Ther"},{"key":"299_CR14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65:415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"key":"299_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","volume":"140","author":"PP Sedghizadeh","year":"2009","unstructured":"Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF (2009) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc 140:61\u201366","journal-title":"J Am Dent Assoc"},{"key":"299_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"299_CR17","unstructured":"Physical status classification system, American Society of Anesthesiologists (2010) available from http:\/\/www.asahq.org\/clinical\/physicalstatus.htm (Accessed April 23)"},{"key":"299_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2001.110306","volume":"91","author":"C Scully","year":"2001","unstructured":"Scully C, Azul AM, Crighton A, Felix D, Field A, Porter SR (2001) Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:189\u2013193","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"299_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","volume":"39","author":"RA Williamson","year":"2010","unstructured":"Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Max Fac Surg 39:251\u2013255","journal-title":"Int J Oral Max Fac Surg"},{"key":"299_CR20","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2007","unstructured":"Black DM (2007) Effects of continuing or stopping alendronate after 5\u00a0years of treatment. J Am Med Assoc 296:2927\u20132938","journal-title":"J Am Med Assoc"},{"key":"299_CR21","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2397\u20132410","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0299-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-011-0299-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0299-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T05:31:56Z","timestamp":1560490316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-011-0299-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,20]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s00774-011-0299-z","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,20]]}}}